Provided by Tiger Trade Technology Pte. Ltd.

Merck

145.31
-3.9700-2.66%
Post-market: 145.310.00000.00%18:31 EDT
Volume:10.23M
Turnover:1.50B
Market Cap:358.50B
PE:114.16
High:149.27
Open:148.95
Low:145.26
Close:149.28
52wk High:156.92
52wk Low:82.01
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.16
T/O Rate:0.41%
Dividend:3.32
Dividend Rate:2.28%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.55
PE(LYR):19.96

Loading ...

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
1 hour ago

Merck, 3M Share Losses Contribute to Dow's 286-Point Drop

Dow Jones
·
2 hours ago

Dow Drops 150 Points on Losses for Shares of Sherwin-Williams Co., Merck

Dow Jones
·
5 hours ago

Spyre Gains After Merck's Drug Succeeds in Skin Disease Trial

Reuters
·
Yesterday

Merck Says Experimental Skin Disease Drug Meets Main Goal in Mid-Stage Study

Reuters
·
Yesterday

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Yesterday

Merck Says Tulisokibart Hits Primary Endpoint in Phase 2b Hidradenitis Suppurativa Trial

Reuters
·
Yesterday

Merck & Co - Study Meets Primary Endpoint Hiscr50 at Week 16 for High- and Medium-Dose Tulisokibart

THOMSON REUTERS
·
Yesterday

Merck's Tulisokibart Met Primary and Key Secondary Endpoints in Phase 2B Study in Patients with Moderate to Severe Hidradenitis Suppurativa (Hs)

THOMSON REUTERS
·
Yesterday

Merck & Co - no Serious or Opportunistic Infections Observed in Study

THOMSON REUTERS
·
Yesterday

Marka S.A. Pays Twelfth Installment Under Amended Bondholder Arrangement

TIPRANKS
·
Yesterday

US Drug Lobby Group PhRMA Names Former House Leader Cantor as CEO

Reuters
·
Yesterday

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 29

Citi Remains a Hold on Merck & Company (MRK)

TIPRANKS
·
Sep 29

Merck Starts Phase 1 Trial of Oral Peptide Developed With Cyprumed's Technology

MT Newswires Live
·
Sep 29

Scotiabank Adjusts PT on Merck & Co. to $180 From $155, Keeps Sector Outperform Rating

MT Newswires Live
·
Sep 29

Cyprumed : Eligible to Receive up to $493.00m in Milestones from Merck & Co Collaboration

THOMSON REUTERS
·
Sep 29

US Research Roundup-Acuity, Dell Technologies, Nike

Reuters
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29